ROYAL BANK OF CANADA - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 27 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$0
-100.0%
184
-98.7%
0.00%
Q4 2017$18,000
+260.0%
13,851
+534.2%
0.00%
Q3 2017$5,000
-28.6%
2,184
-6.1%
0.00%
Q2 2017$7,000
-30.0%
2,326
-17.8%
0.00%
Q1 2017$10,000
+900.0%
2,830
+421.2%
0.00%
Q4 2016$1,000
-50.0%
543
-21.3%
0.00%
Q3 2016$2,0006900.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
GLG LLC 1,524,143$1,966,0000.14%
BVF INC/IL 734,976$948,0000.11%
Old West Investment Management, LLC 77,254$99,0000.06%
Telemetry Investments, L.L.C. 64,464$83,0000.03%
Baupost Group 2,226,839$2,873,0000.03%
NEA Management Company, LLC 370,900$478,0000.02%
IFG Advisory, LLC 49,000$63,0000.01%
Rock Springs Capital Management LP 165,300$213,0000.01%
Virtu Financial LLC 50,290$65,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 133,658$172,0000.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders